Биомаркери

Статии в категория "Биомаркери" - 29 публикации

New Data Demonstrate CD47 Expression Level Helps Predict Response to ALX Oncology’s Evorpacept in Combination with Ziihera (zanidatamab-hrii) in Advanced HER2-Positive Breast Cancer
Биомаркери

New Data Demonstrate CD47 Expression Level Helps Predict Response to ALX Oncology’s Evorpacept in Combination with Ziihera (zanidatamab-hrii) in Advanced HER2-Positive Breast Cancer

- Exploratory analysis from Phase 1b/2 breast cancer trial reinforces CD47 as a predictive biomarker for response, as previously observed in the ASPEN-06 trial in HER2-positive gastric cancer –

4 февруари 2026 г.4 мин
AI Catches More Breast Cancers and Cuts Radiologist Workload by Nearly Half
Биомаркери

AI Catches More Breast Cancers and Cuts Radiologist Workload by Nearly Half

OVER 100,000 Swedish women rolled through mammography machines between 2021 and 2022, each one randomly assigned to have their scans read either by two

4 февруари 2026 г.6 мин
Improved polygenic risk prediction models for breast cancer subtypes in women of African ancestry
Биомаркери

Improved polygenic risk prediction models for breast cancer subtypes in women of African ancestry

Application of multiancestry and ensemble-based approaches yields improved polygenic risk prediction models for breast cancer and its subtypes among women of African ancestry.

4 февруари 2026 г.2 мин
Correction: GRB2 promotes brain metastasis in HER2-positive breast cancer by regulating the Ras/MAPK pathway
Биомаркери

Correction: GRB2 promotes brain metastasis in HER2-positive breast cancer by regulating the Ras/MAPK pathway

Scientific Reports - Correction: GRB2 promotes brain metastasis in HER2-positive breast cancer by regulating the Ras/MAPK pathway

4 февруари 2026 г.3 мин
Gilead wins FDA nod for Trodelvy in HR+/HER2 breast cancer (NASDAQ:GILD)
Биомаркери

Gilead wins FDA nod for Trodelvy in HR+/HER2 breast cancer (NASDAQ:GILD)

Gilead Sciences (GILD) announced Friday that the FDA approved its antibody-drug conjugate Trodelvy for adult patients with HR+/HER2- metastatic breast cancer. R...

4 февруари 2026 г.2 мин
New radioimmunotherapy approach shows potential to cure HER2-positive breast cancer
Биомаркери

New radioimmunotherapy approach shows potential to cure HER2-positive breast cancer

A new radioimmunotherapy approach has the potential to cure human epidermal growth factor receptor 2 (HER2)-positive breast cancer, according to new research pu...

4 февруари 2026 г.2 мин

Страница 3 от 5 • Общо 29 статии